Jessie L Bender, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4181 Hospital Dr Ne Ste 104, Covington, GA 30014 Phone: 770-385-8954 Fax: 770-385-8590 |
Dr. Michelle Denise White, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4181 Hospital Dr Ne, Suite104, Covington, GA 30014 Phone: 770-385-8954 Fax: 770-385-8590 |
Dr. Zsakeba Henderson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 25 Providence Dr, Covington, GA 30016 Phone: 770-788-7205 |
Cathy Toner Larrimore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4181 Hospital Dr Ne, Suite 104, Covington, GA 30014 Phone: 770-385-8954 Fax: 770-385-8590 |
Sherley C Samuels, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4181 Hospital Dr Ne, Suite 104, Covington, GA 30014 Phone: 770-385-8954 Fax: 770-385-8590 |
Dr. Meridith Farrow, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4181 Hospital Dr Ne Ste 104, Covington, GA 30014 Phone: 770-385-8954 Fax: 770-385-8590 |
Dr. Ray S Greco Ii, D.O. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4143 Hospital Dr Ne, Covington, GA 30014 Phone: 770-787-2674 Fax: 770-787-6222 |
News Archive
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
Researchers at the University of Liverpool have developed a breakthrough technology that identifies molecular markers in early lung cancer.
Vangent, Inc., a leading global provider of information management and strategic business process solutions, announced today it was awarded a $20 million contract by the Department of Defense (DoD) to implement an integrated Single Sign-On (SSO) and Context Management capability throughout the Military Health System.
New research by German scientists has uncovered another form of coronavirus polymerase. The current polymerase thought to be used for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral RNA-dependent RNA polymerase (RdRp) for replication and transcription. It contains a monomeric enzyme with the catalytic subunit nsp12, two copies of subunit nsp8, and one copy of subunit nsp7.
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.
› Verified 5 days ago